Target intelligence / Profile preview

V-type proton ATPase subunit B, kidney isoform (ATP6V1B1)

Target
ATP6V1B1
Molecular classification
Enzyme (specifically, a proton pump/ATPase), Transporter (proton transporter, acidification-related), Multisubunit enzyme complex component (V1 sector of V-ATPase)
01

Overview

V-type proton ATPase subunit B, kidney isoform (ATP6V1B1) is the non-catalytic B1 subunit of the cytosolic V1 sector of vacuolar ATPase (V-ATPase), a multisubunit enzyme complex responsible for proton (H+) transport across intracellular organelle membranes and, in some cells, across the plasma membrane. This acidification is essential for processes such as urinary acidification in the kidney, protein sorting, endocytosis, synaptic vesicle function, and maintenance of pH in the inner ear. The B1 subunit is primarily expressed in the kidney and inner ear. Mutations in ATP6V1B1 disrupt normal acid-base homeostasis and are causative for distal renal tubular acidosis associated with progressive sensorineural hearing loss[1][2][3][7].

Other names
ATPase H+ transporting V1 subunit B1ATP6B1VATBVPP3V-ATPase subunit B1RTA1BVma2Endomembrane proton pump 58 kDa subunitVacuolar proton pump subunit B1Renal tubular acidosis with deafnessDRTA2H(+)-transporting two-sector ATPase 58kD subunitH+-ATPase beta 1 subunitvacuolar proton pump 3vacuolar proton pump subunit 3
02

Mechanism of action

Drugs targeting this enzyme would likely inhibit or modulate ATPase-mediated proton transport, interfering with organellar and urinary acidification, but clinically relevant inhibitors are not listed; no approved drugs known to target specifically ATP6V1B1 in humans[2][3][7].

03

Biological functions

Acidification of intracellular organellesUrinary acidification (proton secretion in renal tubule)Regulation of pH in inner ear endolymphProtein sortingZymogen activationReceptor-mediated endocytosisSynaptic vesicle proton gradient generation
04

Disease associations

Renal tubular acidosis (especially with sensorineural deafness)Bone demineralization/metabolic acidosis (as a symptom of above)Hearing loss (sensorineural)
05

Safety considerations

Loss of function or on-target inhibition may lead to metabolic acidosis, nephrocalcinosis, bone demineralization, and hearing loss due to failure of normal acidification in kidney and inner ear[3][1]
06

Biomarkers

Mutations are biomarkers for distal renal tubular acidosis with sensorineural deafness (diagnostic genetic marker)[3]

Beyond the preview

Go deeper on V-type proton ATPase subunit B, kidney isoform (ATP6V1B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-type proton ATPase subunit B, kidney isoform (ATP6V1B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call